A case of cerebral tuberculosis after liver transplant and literature review

Experimental and Clinical Transplantation

Volumn 12, Issue SUPPL. 1, 2014, Pages 117-119

  Zeyneb Tunca, M ^a   Akçay, Eda Yilmaz ^a   Moray, Gökhan ^a   Özen, Özlem ^a   Handan Ozdemir B ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Cerebral needle biopsy; Cerebral tuberculosis; Liver transplant

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; PREDNISOLONE; TUBERCULOSTATIC AGENT; ANTIVIRUS AGENT;

ABDOMINAL SWELLING; ACID FAST BACTERIUM; ADULT; ANTIVIRAL THERAPY; ARTICLE; ASTHENIA; BRAIN BIOPSY; BRAIN DAMAGE; BRAIN STEM INJURY; CASE REPORT; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; ESOPHAGUS VARICES; GLIOSIS; GRAND MAL EPILEPSY; GRANULOMA; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HISTIOCYTE; HUMAN; HUMAN TISSUE; HYPERSPLENISM; HYPOXIA; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; LIMB WEAKNESS; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; LYMPHOCYTE; MALE; METABOLIC ENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; RESPIRATORY TRACT INTUBATION; THROMBOCYTOPENIA; VIRUS ACTIVATION; VIRUS REACTIVATION; BIOPSY; COMPLICATION; DRUG EFFECTS; END STAGE LIVER DISEASE; FATALITY; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; MICROBIOLOGY; OPPORTUNISTIC INFECTIONS; PATHOGENICITY; RECURRENT DISEASE; TIME; TREATMENT OUTCOME; TUBERCULOMA, INTRACRANIAL; VIROLOGY;

ADULT; ANTITUBERCULAR AGENTS; ANTIVIRAL AGENTS; BIOPSY; END STAGE LIVER DISEASE; FATAL OUTCOME; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER TRANSPLANTATION; MALE; OPPORTUNISTIC INFECTIONS; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOMA, INTRACRANIAL; VIRUS ACTIVATION;

EID: 84897449704     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.25Liver.P18     Document Type: Article

References (8)

1. Muñoz P, Rodríguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid-organ transplants. Clin Infect Dis. 2005;40(4):581-587.
2. Subramanian A, Dorman S; AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis in solid-organ transplant recipients. Am J Transplant. 2009;9(suppl 4):S57-S62.
3. Guzel A, Tatli M, Aluclu U, Yalcin K. Intracranial multiple tuberculomas: 2 unusual cases. Surg Neurol. 2005;64(suppl 2):S109-S112.
4. Madhavan K, Widi G, Shah A, Petito C, Gallo BV, Komotar RJ. Tuberculoma of the brain with unknown primary infection in an immunocompetent host. J Clin Neurosci. 2012;19(9):1320-1322.
5. Ha YE, Joo EJ, Park SY, et al. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solidorgan transplant recipients. Transpl Infect Dis. 2012;14(6):626-634.
6. Torre-Cisneros J, Doblas A, Aguado JM, et al. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis. 2009;48(12):1657-1665.
7. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis. 1998;27(5):1266-1277.
8. Aguado JM, Torre-Cisneros J, Fortún J, et al. Tuberculosis in solidorgan transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis. 2009;48(9):1276-1284.